Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: César Luis Ramírez-Tortosa J Pascual |
| Publication date | October 2, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |